Investigators conducted a systematic review and meta-analysis to assess the effect of pharmacotherapy on anxiety symptoms in individuals with bipolar disorder.
Investigators assessed the relationship between clinical and cognitive features and oddball neural deviations across the schizophrenia-bipolar spectrum.
A comparative list of psychotropic medications with their mood disorder indications (bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others).
Researchers conducted a meta-analysis of nearly 42,000 individuals with bipolar disorder and more than 370,000 control group participants.
Mental health disorders are associated with increased COVID-19-related mortality.
The approval was based on data from 27 clinical studies, including the phase 3 ENLIGHTEN-1 and ENLIGHTEN-2 studies.
In both trials, BXCL501 demonstrated statistically significant, rapid and durable improvements vs placebo across multiple agitation scales.
Adolescent patients with bipolar disorder are at a uniquely vulnerable period in their lives, which presents challenges in treatment. What are some of their experiences and risks that medical professionals should be looking out for and communicating to parents?
The sNDA submissions are supported by data from 2 global randomized, double-blind, placebo-controlled phase 3 studies.
In this study, patients were assessed for hospital stay on the basis of treatment regimen.